Swissport increases its pharmaceutical network to include 24 certified facilities.

Swissport has expanded its global pharmaceutical logistics network by certifying its Düsseldorf facility as part of its IATA CEIV Pharma-certified centres, bringing the total to 24 worldwide. This certification enhances Swissport's commitment to the safe and compliant handling of pharmaceutical cargo. As the company invests in temperature-controlled infrastructure in key life science markets, it adds dedicated facilities in Manchester, New York, and Shanghai. With a focus on biologics and temperature-sensitive therapies, Swissport aims to meet rising market demands while ensuring safety and compliance in its operations.